Most Roundup lawyers run one play. They argue Monsanto failed to warn consumers about the cancer risk and should pay for that failure. We run that play too — but we lead with a stronger one. We attack Roundup as a defective product, full stop. Whether Monsanto warned anyone or not, the product itself is unreasonably dangerous and never should have been sold.
Two Roads To A Defective-Product Verdict
Product liability law in most states recognizes several theories on which an injured person can sue a manufacturer. In Roundup litigation, two of them carry most of the weight: failure-to-warn and strict product liability based on a design defect. Both are valid. Both can win. But they ask juries to answer different questions, and they put different kinds of pressure on Monsanto.
Failure-to-Warn
Monsanto knew (or should have known) about Roundup's cancer risk and failed to provide adequate warning to consumers and applicators. The remedy: damages for the harm caused by that inadequate warning.
Question for the jury: Did the label say enough?
Strict Product Liability
Roundup, as designed, is unreasonably dangerous. No warning could make it safe to spray on crops, lawns, and orchards. The product is the defect.
Question for the jury: Should this product ever have been sold?
What Failure-To-Warn Requires
A failure-to-warn case usually requires the plaintiff to establish, by a preponderance of the evidence, that:
- The product (Roundup) was defective because it lacked an adequate warning;
- Monsanto knew or should have known about the risk that should have been warned about;
- The inadequate warning was a substantial factor in causing the plaintiff's injury;
- If a different warning had been given, the plaintiff (or a learned intermediary, depending on the state) would have acted differently.
The vulnerability is in that last element. Monsanto's defense playbook on failure-to-warn is well-developed: argue the warning would not have changed behavior, argue the EPA's "not likely to be carcinogenic" conclusion preempted any duty to warn, argue the plaintiff or applicator already knew what they needed to know. None of those arguments are necessarily winning — but each one provides a foothold.
What Strict Liability Requires
A strict-product-liability claim based on a design defect asks a different question. The plaintiff must establish that:
- Roundup was defective in design;
- The defect existed when the product left Monsanto's control;
- The defect caused the plaintiff's injury.
The defining feature: Monsanto's mental state is largely irrelevant. The case does not turn on what Monsanto knew, when Monsanto knew it, or what Monsanto told consumers. It turns on the product itself. If a jury concludes that glyphosate-based Roundup, as designed, posed a risk that outweighed its utility — a risk that no warning could have neutralized — Monsanto loses, regardless of what it said or did not say in fine print.
That is a much harder thing for a defendant to escape, because Monsanto cannot defend the product without defending the design. Monsanto's own internal documents — the Monsanto Papers — show its scientists understood the genotoxic mechanism by which glyphosate damages B-cell lymphocytes. Monsanto cannot un-know that science by pointing at a bottle label.
Why Strict Liability Worked Against Tobacco
The Alvarez Law Firm has recovered over $100 million from cigarette manufacturers under a strict-product-liability framework. The reason that framework worked against Big Tobacco is the same reason it works against Monsanto.
For decades, cigarette manufacturers defended themselves by arguing that smokers knew about the cancer risk. Failure-to-warn claims were difficult against tobacco for that reason — the warning was on every pack since the 1960s. What broke through was a shift in legal theory: the cigarette is the defect. The product is unreasonably dangerous regardless of what was on the label. Once juries got hold of that question, they returned verdicts.
Why Roundup Fits The Same Mold
Three features of glyphosate-based Roundup line up with the strict-liability framework almost perfectly:
- The injury is foreseeable from the design itself. Glyphosate causes oxidative stress and DNA damage in human B-cell lymphocytes. That mechanism is the precursor to Non-Hodgkin Lymphoma. The link does not depend on what label Monsanto applied; it depends on what Monsanto put in the bottle.
- Safer alternatives existed. Strict-liability design-defect analysis often involves comparing the challenged design to alternatives. Less-toxic herbicides existed when Roundup was first sold. Mechanical and integrated pest-management approaches existed. Monsanto's choice to design Roundup the way it did, when alternatives were available, supports the design-defect theory.
- The warning would not have neutralized the risk. Even with a perfect cancer warning, applicators — farmers, landscapers, groundskeepers — still had to spray the product to do their jobs. The risk was structural, not informational.
What This Means For Case Value
Strict-liability cases tend to be valued differently than failure-to-warn-only cases. The reasons are practical: a strict-liability case is harder to dispose of on summary judgment, harder to win on appeal once a jury verdict comes in, and broader in the kinds of damages it supports. None of that is a guarantee of any particular result — every case is different and no one can predict outcomes in advance — but the difference between the two theories shows up in how cases get evaluated, settled, or tried.
We pursue both theories where they apply. The failure-to-warn theory still has work to do. But strict liability is where we lead, because it puts the most pressure on Monsanto and reserves the broadest path to a meaningful verdict.
Bottom Line
Most Roundup firms can run failure-to-warn. We can too — and we do. What sets our cases apart is that we lead with strict product liability, the same framework we used to take more than $100 million from Big Tobacco. That theory does not require us to prove what Monsanto knew or when it knew it. It requires us to prove the product was defective. And the science, the Monsanto Papers, and the design of glyphosate-based Roundup all point to that conclusion.
If you or a family member used Roundup and were diagnosed with Non-Hodgkin Lymphoma, B-cell Lymphoma, Chronic Lymphocytic Leukemia, Hairy Cell Leukemia, or Multiple Myeloma, we would like to evaluate your case. The free case review is exactly that: free. There is no obligation, and no fee unless we recover for you.
